Approach to dealing with acute heart failure in cats and dogs
In Pract. June 2023;45(5):252-266. 7 Refs
Melanie Hezzell1 1 University of Cambridge, The Old Schools, Trinity Ln, Cambridge CB2 1TN, United Kingdom.
Author Abstract
Background: Unfortunately, heart disease is common in both dogs and cats and may eventually result in congestive heart failure (CHF). However, the clinical signs of CHF overlap with other causes of respiratory compromise. As such, differentiating cardiac from non-cardiac causes of respiratory distress is a common diagnostic challenge in emergency veterinary practice. The general principles of heart failure management can be applied to a broad range of cardiac diseases; identifying a cardiac cause for the clinical signs is therefore more important than making a definitive diagnosis in the acute phase of heart failure. Nevertheless, there is no ‘one-size-fits-all’ recipe for treatment and the approach needs to be tailored to the individual (eg, severity of clinical signs, comorbidities, patient demeanour and so on). Although the information in this article is organised linearly, the approach to an emergency case seldom follows the structure used in more stable patients. For example, a dog or cat presenting with significant dyspnoea will typically require treatment (eg, supplementary oxygen ± light sedation) before physical examination and diagnostic testing, and some diagnostic tests may need to be postponed until the patient is stable enough to safely undergo them; therefore, the initial treatment plan is often based on a working, rather than a definitive, diagnosis.
Aim of the article: This article provides an overview of the diagnosis and management of acute heart failure, highlighting similarities and differences between dogs and cats. The aim is to help practitioners approach these cases with more confidence.
|
 |
Article Tools:
Archives Highlights:
Investigation of maternal mortality and stillbirth in feline dystocia after emergency obstetric care interventions: a retrospective analysis.
Medical treatment was successful in 17% of patients, and 83% underwent surgical treatment for dystocia. Ovariohysterectomy (59%) was the most common surgical method, followed by conservative caesarean section (35%).
|
A public health campaign to increase awareness of the risk of dog bites in South Australia.
Over one third (36-37%) of dog owners and 25-29% of non-dog owners had been previously bitten by a dog, although most did not require medical attention. Approximately 70% of dog owners believed it was safe for strangers to approach their dog, 34-37% allowed children or other people to pat their dog without permission, and less than half separated their dog from visitors or delivery people. In contrast, few of the non-dog owners allowed their children to pat a dog without the owner's permission and only 2% allowed them to play with dogs without supervision.
|
Case Series: Computed Tomography Features of Extraskeletal Osteosarcoma in Six Dogs.
Although the presence of intralesional mineralization is not a pathognomonic finding, it was consistently identified in the present case series. Therefore, exOSA should be considered in the differential diagnosis when mineralization occurs in a mass unrelated to osseous structures.
|
Efficacy, safety and interval from end of treatment to estrus in cats treated with an ultra-low dose megestrol acetate protocol for suppression of reproductive activity.
Twenty-eight queens were treated orally with 11.5 µg/kg/day of megestrol acetate (MA) for one to six months. MA suppressed reproductive function effectively in 27/28 queens. Transient mammary and uterine hyperplasia were detected in four (14 %) and three (11 %) queens, respectively, treated for more than four months, without associated clinical signs. Significant but reversible weight gain was observed in 85 % of the animals. The resumption of cyclicity occurred on average 6 weeks after the end of treatment but was influenced by the duration of treatment and seasonality.
|
The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus).
Every day, rabbits produced a median of 75 g (range, 9 to 145 g) of feces, 226 fecal pellets (range, 12 to 412 pellets), and 151 mL (range, 5 to 420 mL) of urine. Metoclopramide, cisapride, pyridostigmine, and capromorelin had no effect on fecal production (both weight and number of pellets), food intake, urine production, or water intake compared to placebo at 24, 48, or 72 hours after administration.
|
|